Eczema overview: Difference between revisions

Jump to navigation Jump to search
Line 29: Line 29:


==Screening==
==Screening==
 
Using the [[Hanifin and Rajka criteria]]as the gold standard, [[eczema]] is commonly [[diagnosed]] when 3 out of 4 [[major criteria]], or 3 out of 23 [[minor criteria]] have been satisfied. [[United Kingdom Working Party diagnostic criteria]] is another alternative method of diagnosing eczema, which only requires 1 mandatory criterion, and 5 major criteria, and no laboratory testing is required. To assess the long-term control of this [[disease]], three methods are used, namely the repeated measurement of [[outcomes]], the number of [[medications]] used, and the occurrence of [[flares]] or [[remissions]].


==Natural History, Complications, and Prognosis==
==Natural History, Complications, and Prognosis==

Revision as of 01:58, 19 May 2022

Eczema Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Eczema from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Social Impact

Future or Investigational Therapies

Case Studies

Case #1

Eczema On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Eczema

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Eczema

CDC on Eczema

Eczema in the news

Blogs on Eczema

Directions to Hospitals Treating Eczema

Risk calculators and risk factors for Eczema

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.

Overview

Eczema is a form of dermatitis, or inflammation of the upper layers of the skin.

The term "eczema" is broadly applied to a range of persistent skin conditions. These include dryness and recurring skin rashes characterized by one or more of these symptoms: redness, skin edema, itching and dryness, crusting, flaking, blistering, cracking, oozing, or bleeding. Areas of temporary skin discoloration are sometimes due to healed lesions, although scarring is rare.

Historical Perspective

Over the years, dermatological conditions have become manifested in individuals. It was in the earlier part of the 20th century when the term atopic dermatitis was coined. The evolution of concepts from the standpoint of historical perspectives was observed, wherein significant insights as to the nature of the disease were derived.

Classification

Eczema can be classified in different forms. It could be based on location (hand eczema), specific appearance (discoid), or etiology (varicose eczema). A simplified nomenclature of allergy-related diseases was released by the European Academy of Allergology and Clinical Immunology (EAACI) in 2001.

Pathophysiology

There are two main theories on the existence of atopic dermatitis, also known as atopic eczema. These are the inside-out theory, and the outside-in hypothesis.

Causes

There are several possible causes of eczema, majority of which are genetic in origin. Adverse drug effects also manifest as eczema.

Differentiating Eczema from other Diseases

Several medical conditions can mimic eczema, with overlapping features. These conditions could be due to an inflammatory, infectious, immunodeficiency, or a nutritional deficiency problem. It is important to differentiate one from another to render proper medical treatment.

Epidemiology and Demographics

Eczema has been noted to have affected 1-3% of the adult population and 15-20% of the children population worldwide. In the United States, the prevalence is 10.7% in children and 7.2% in adults. Eczema is more commonly observed in males, particularly in those with severe cases, and has a late-onset.

Risk Factors

Family history and genetic mutation in the FLG gene are the two main risk factors of acquiring eczema.

Screening

Using the Hanifin and Rajka criteriaas the gold standard, eczema is commonly diagnosed when 3 out of 4 major criteria, or 3 out of 23 minor criteria have been satisfied. United Kingdom Working Party diagnostic criteria is another alternative method of diagnosing eczema, which only requires 1 mandatory criterion, and 5 major criteria, and no laboratory testing is required. To assess the long-term control of this disease, three methods are used, namely the repeated measurement of outcomes, the number of medications used, and the occurrence of flares or remissions.

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Social Impact

Future or Investigational Therapies